Skin Cancer Outcomes Consortium
Skin Cancer Outcomes Consortium's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $6,340 for Emily Karn, Executive Director (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $6,507. It is higher than the D + F figure for 4 of 116 peer organizations selected under the disclosed tier Same NTEE major group (H), nationwide + size band 0.67–1.5× revenue (approximately 3%; median $61,815). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Skin Cancer Outcomes Consortium, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE major group (H), nationwide + size band 0.67–1.5× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| The International Genomics Consortium | AZ | $281,106 | $726,166 |
| Seneca Diabetes Foundation | NY | $288,181 | $50,876 |
| Foundation For Cardiovascular Medicine And Research | CA | $289,213 | $33,497 |
| Grassrootshealth | CA | $289,673 | $74,149 |
| National Canine Cancer Foundation Inc | AZ | $289,739 | $43,917 |
| National Bone Marrow Transplant Link | MI | $290,191 | $92,496 |
| Caroline Symmes Inc | IN | $290,676 | $9,698 |
| Conquering Congenital Heart Disease | WI | $291,957 | $45,690 |
View the organization record and available filings on ProPublica